Skip to content
Search

Latest Stories

Exclusive: Artificial pancreas trial hailed as ‘new era for healthcare’

Exclusive: Artificial pancreas trial hailed as ‘new era for healthcare’

AN artificial pancreas trial currently running in the UK will help the healthcare sector leap to a new digital era, the NHS national speciality adviser for diabetes has said.

As many as 1,000 NHS patients with type 1 diabetes are taking part in a study where their blood sugar levels will be monitored and the amount of insulin given via a pump will be automatically adjusted. The trial started on July 19 at 25 adult centres, and six paediatric centres around the country; it is expected to be completed by August 2022.


Professor Partha Kar told Eastern Eye, “Patients can go home after the set-up is done (at a clinic). We can monitor data remotely, from the clinic. This will be the first trial of this kind and be the future for clinical trials going ahead. I think this’ll be a new digital chapter for the healthcare sector.

PSK pcture Professor Partha Kar

“The pandemic has fastened the change. And I think this is a good start.”

People with type 1 diabetes – who comprise eight per cent of people with diabetes in the UK - cannot produce enough insulin. They need daily doses of the hormone to keep blood sugar levels under control, delivered via an injector pen or a pump.

Under the new ‘closed loop technology’ trial, finger prick tests can be eliminated, and life-threatening hypoglycaemic attacks could be prevented.

Kar explained how the technology works.

“It’s called an artificial pancreas. We want to see whether we can create what the pancreas does inside the body. You have a sensor on the arm with a little pump on the hip.

“Instead of pricking your finger, you have a sensor that picks up the glucose level and that reading is transmitted to your insulin pump. You don't have to inject the insulin as the pump will work out how much insulin is needed and give you the necessary quantity,” Kar told Eastern Eye.

According to him, in the past three or four years, several companies have been developing artificial pancreas technology.

“But the issue is that you can't fund it without the evidence. So that’s what we're doing. We are saying, ‘let's put 1000 patients around the country- with different age groups, different needs - on this artificial pancreas. And let's see the result. Does it improve their glucose level, their quality of life? That’s what we are trying to find out through this trial.”

Medtronic, Tandem Diabetes Care, Dana (with Prof Roman Hovorka engineered algorithm) and Medtrum are the four major companies in the UK engaged in the development of the artificial pancreas.

Kar described the ongoing trial as crucial for diabetes treatment.

“The artificial pancreas trial is for type 1 diabetes patients. A positive outcome for this project can give a permanent solution to the disease. Then the healthcare sector can concentrate on type 2 diabetes, which is a bigger problem,” he said.

Type 2 diabetes is a lifelong disease where the insulin (which regulates blood sugar levels) is not effective and leads to high sugar in the blood. People with type 2 diabetes are said to have insulin resistance.

Kar said, “In UK about seven per cent of the population has type 2 diabetes. In India, it's a rising issue simply because of the higher risk of our ethnicity. More south Asian people in the UK are at risk.

“Our diet, lifestyle, consumption of sweets during religious festivals can lead to more people towards having type 2 diabetes. It is a rising issue. South Asians in the UK have got a higher prevalence of type 2 diabetes than the average (white) population.

“Look at the data around Covid - people with diabetes were severely affected by the pandemic. The ongoing trial, I think, will create awareness about diabetes among people, irrespective of the type, which is a good thing.”

Kar pointed out that diagnosis of type 2 diabetes among younger people in the UK is an alarming trend due to modern lifestyle and lack of exercise.

However, the national diabetic adviser cautioned against drawing simplistic conclusions.

“What people should not assume is that if you have type 1 diabetes and you have an ‘artificial pancreas’, everything is sorted. Absolutely not. You still need a healthy lifestyle. It doesn't matter how artificial your pancreas is, without the right food and lifestyle you are at risk.”

More For You

Minouche Shafik

Shafik served as deputy governor for markets and banking at the Bank of England between August 2014 and February 2017.

Reuters

Starmer appoints Minouche Shafik as chief economic adviser in reshuffle

Highlights:

  • Minouche Shafik named chief economic adviser to Keir Starmer.
  • Darren Jones moves into Downing Street role; James Murray replaces him.
  • Wider reshuffle includes changes in Starmer’s private office and communications.
  • Appointment comes ahead of a budget expected to include further tax rises.

Prime minister Keir Starmer has named Minouche Shafik, a former deputy governor of the Bank of England, as his chief economic adviser. The appointment comes as he looks to strengthen his team ahead of what is expected to be a difficult end to the year.

Keep ReadingShow less
modi putin

Before their formal meeting, Putin offered Modi a ride in his Aurus limousine.

X/@narendramodi

Six key takeaways from the SCO summit

INDIAN prime minister Narendra Modi met Russian president Vladimir Putin and Chinese president Xi Jinping on the sidelines of the Shanghai Cooperation Organisation (SCO) summit in Tianjin, China.

Modi pressed for ending the Ukraine conflict at the earliest, reaffirmed India’s long-standing ties with Russia, and discussed trade and border issues with Xi.

Keep ReadingShow less
Afghanistan earthquake

Afghan volunteers and Taliban security personnel carry an earthquake victim evacuated by a military helicopter from the Nurgal district of Kunar province onn September 1, 2025.

Getty Images

Afghanistan earthquake kills more than 800, thousands injured

A MAJOR rescue operation was underway in Afghanistan on Monday after a powerful earthquake and several aftershocks destroyed homes in a remote mountainous region, killing more than 800 people, according to Taliban authorities.

The quake struck just before midnight and was felt as far as Kabul and in Pakistan’s capital, Islamabad.

Keep ReadingShow less
Ganpati festival

The Ganpati festival celebrates Ganesha as the god of new beginnings, and the god of wisdom and intelligence. (Photo: Getty Images)

Getty Images

Hindu community centre in London damaged in fire after Ganapati Visarjan event

A HINDU community centre in east London caught fire on Saturday evening, causing major damage to the building. The London Fire Brigade brought the fire under control and confirmed that no injuries were reported.

The incident took place at the Shree Sorathia Prajapati Community Centre on Cleveland Road in Ilford, which had been decorated for a Ganapati Visarjan event attended by members of the Hindu community.

Keep ReadingShow less
Modi ,Xi & Putin

Narendra Modi talks with Vladimir Putin and Xi jinping ahead of the Shanghai Cooperation Organization (SCO) Summit 2025 at the Meijiang Convention and Exhibition Centre in Tianjin on September 1, 2025.

Getty Images

SCO declaration slams Pahalgam attack, calls for united action on terror

Highlights:

  • SCO condemns terror attack in Pahalgam and echoes India’s stance on “double standards”.
  • Leaders call for justice for perpetrators of attacks in Pahalgam and Balochistan.
  • Declaration criticises Israeli military strikes in Gaza causing civilian casualties.
  • SCO stresses UN’s central role in global counter-terrorism strategy.

THE SHANGHAI Cooperation Organisation (SCO) on Monday condemned the terror attack in Pahalgam and agreed with India’s position that “double standards” in tackling terrorism are not acceptable.

Keep ReadingShow less